The 48 linked references in paper A. Vatazin V., A. Kildjushevskiy, V. Fedulkina A., A. Faenko P., А. Ватазин В., А. Кильдюшевский В., В. Федулкина А., А. Фаенко П (2017) “МЕХАНИЗМЫ ОТТОРЖЕНИЯ ПОЧЕЧНОГО АЛЛОТРАНСПЛАНТАТА И ИММУНОЛОГИЧЕСКАЯ ТОЛЕРАНТНОСТЬ // RENAL ALLOGRAFT REJECTION MECHANISMS AND IMMUNOTOLERANCE” / spz:neicon:nefr:y:2016:i:6:p:33-41

  1. Johnston O, Rose C, Landsberg D et al. Nephrectomy after transplant failure: current practice and outcomes Am J Transplant 2007; 7(8): 1961-1967. doi: 10.1111/j.1600-6143.2007.01884.x
  2. O'Leary JG, Samaniego M, Barrio MC et al. The Influence of Immunosuppressive Agents on the Risk of De Novo DonorSpecific HLA Antibody Production in Solid Organ Transplant Recipients. Transplantation. 2016; 100(1): 39-53 [doi: 10.1097/ TP.0000000000000869]
  3. 2): 101-116 doi: 10.1111/j.1399-0039.2009.01291.x 7. Дмитриева НГ, Яковчик ОН, Ватазин АВ и др. Система гистосовместимости при трансплантации почки. Альманах клинической медицины 2014; 31: 83-87 [Dmitrieva NG, Iakovchik ON, Watazin AV i dr. Sistema gistosovmestimosti pri transplantatcii pochki. Al`manakh clinicheskoi` meditciny` 2014; 31: 83-87]
  4. Caron E, Kowalewski DJ, Chiek Koh C et al. Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry. Mol Cell Proteomics 2015; 14(12): 3105-3117. doi: 10.1074/mcp.M115.052431
  5. Wei RQ, Schwartz CF, Lin H et al. Anti-TNF antibody modulates cytokine and MHC expression in cardiac allografts. J Surg Res 1999; 81(2): 123-128. doi: 10.1006/jsre.1998.5303
  6. Pabón MA, Navarro CE, Martin R et al. Minor histocompatibility antigens as risk factor for poor prognosis in kidney transplantation. Transplant Proc 2011; 43(9): 3319-3323. doi: 10.1016/j. transproceed.2011.09.007
  7. Breman E, van Miert PP, van der Steen DM et al. HLA monomers as a tool to monitor indirect allorecognition. Transplantation 2014; 97(11): 1119-1127. doi: 10.1097/TP.0000000000000113
  8. Harper SJ, Ali JM, Wlodek E et al. CD8 T-cell recognition of acquired alloantigen promotes acute allograft rejection. Proc Nati Acad Sci U S A 2015; 112(41): 12788-12793. doi: 10.1073/ pnas.1513533112
  9. Ali J, Bolton E, Saeb-Parsy K. et al. Targeting indirect pathway CD4 T-cell alloresponses in the prevention of chronic transplant rejection. Lancet 2015; 385(1): 17. doi: 10.1016/S01406736(15)60332-4
  10. Lin CM, Gill RG. Direct and indirect allograft recognition: pathways dictating graft rejection mechanisms. Curr Opin Organ Transplant 2016; 21(1): 40-44. doi: 10.1097/ MOT.0000000000000263
  11. Taylor AL, Negus SL, Negus M. et al. Pathways of helper CD4 T cell allorecognition in generating alloantibody and CD8 T cell alloimmunity. Transplantation 2007; 83(7): 931-937. doi: 10.1097/01.tp.0000257960.07783.e3
  12. Weist BJ, Schmueck M, Fuehrer H. et al. The role of CD4(+) T cells in BKV-specific T cell immunity. Med Microbiol Immunol 2014; 203(6): 395-408. doi: 10.1007/s00430-014-0348-z
  13. Phillips S, Kapp M, Crowe D. et al. Endothelial activation, lymphangiogenesis, and humoral rejection of kidney transplants. Hum Pathol 2016;51:86-95. doi: 10.1016/j.humpath.2015.12.020
  14. 4; 33(3): 212-233. doi: 10.3109/08830185.2013.829470 20. Vogel I, Kasran A, Cremer J. et al. CD28/CTLA-4/B7 costimulatory pathway blockade affects regulatory T-cell function in autoimmunity. Eur J Immunol 2015; 45(6): 1832-1841. doi: 10.1002/eji.201445190
  15. Berg M, Zavazava N. Regulation of CD28 expression on CD8+ T cells by CTLA-4. J Leukoc Biol 2008; 83(4): 853-863. doi: 10.1189/jlb.0107065
  16. Linsley PS, Brady W, Urnes M. et al. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991; 174: 561-569. doi: 10.1084/jem.174.3.561
  17. Ford ML, Larsen CP. Translating costimulation blockade to the clinic: lessons learned from three pathways. Immunol Rev 2009; 229 (1): 294-306. doi: 10.1111/j.1600-065X.2009.00776.x.
  18. Pilat N, Sayegh MH, Wekerle T. Costimulatory pathways in transplantation. Semin Immunol. 2011; 23(4): 293-303. doi: 10.1016/j.smim.2011.04.002
  19. Harada H, Salama AD, Sho M et al. The role of the ICOSB7h T cell costimulatory pathway in transplantation immunity. J Clin Invest 2003; 112(2): 234-243. doi: 10.1172/jci200317008
  20. Dai H, Peng F, Lin M. et al. Anti-OX40L monoclonal antibody prolongs secondary heart allograft survival based on CD40/CD40L and LFA-1/ICAM-1 blockade. Transpl Immunol 2015; 32(2):84-91. doi: 10.1016/j.trim.2015.01.001
  21. Wells AD, Walsh MC, Sankaran D et al. T cell effector function and anergy avoidance are quantitatively linked to cell division. J Immunol 2000; 165(5): 2432-2443. doi: 10.4049/ jimmunol.165.5.2432
  22. del Rio ML, Buhler, Gibbons C et al. PD-1/PD-L1, PD-1/ PD-L2, and other co-inhibitory signaling pathways in transplantation. Transpl Int 2008; 21(11): 1015-1028. doi: 10.1111/j.14322277.2008.00726.x
  23. Masson P, Henderson L, Chapman JR et al. Belatacept for kidney transplant recipients. Cochrane Database Syst Rev 2014; 11: 1-65. doi: 10.1002/14651858.CD010699.pub2
  24. Rančić N., Dragojević-Simić V., Vavić N et al. Tacrolimus concentration/dose ratio as a therapeutic drug monitoring strategy: the influence of gender and comedication. Vojnosanitetski Pregl 2015; 72(9): 813-822. doi:10.2298/VSP140905005R
  25. Sarwal MM. Fingerprints of transplant tolerance suggest opportunities for immunosuppression minimization. Clin Biochem 2016; 49(4-5): 404-410. doi: 10.1016/j.clinbiochem.2016.01.007
  26. Gracon AS, Wilkes DS. Lung transplantation: chronic allograft dysfunction and establishing immune tolerance. Hum Immunol 2014; 75(8): 887-894. doi: 10.1016/j.humimm.2014.06.015
  27. LaFlam TN, Seumois G, Miller CN et al. Identification of a novel cis-regulatory element essential for immune tolerance. J Exp Med 2015; 212(12): 1993-2002. doi: 10.1084/jem.20151069
  28. Yamano T, Steinert M, Klein L. Thymic B Cells and Central T Cell Tolerance. Front Immunol 2015; 6: 376. doi: 10.3389/ fimmu.2015.00376
  29. Laan M, Peterson P. The many faces of aire in central tolerance. Front Immunol 2013; 4: 326. doi: 10.3389/ fimmu.2013.00326
  30. Delgoffe GM, Powell JD. Feeding an army: The metabolism of T cells in activation, anergy, and exhaustion. Mol Immunol 2015; 68: 492-496. doi: 10.1016/j.molimm.2015.07.026
  31. Asashima H, Tsuboi H, Takahashi H et al. The anergy induction of M3 muscarinic acetylcholine receptor-reactive CD4+ T cells suppresses experimental sialadenitis-like Sjögren’s syndrome. Arthritis Rheumatol 2015; 67(8): 2213-2225. doi: 10.1002/art.39163
  32. O’Konek JJ, Kato S, Takao S et al. β-mannosylceramide activates type I natural killer t cells to induce tumor immunity without inducing long-term functional anergy. Clin Cancer Res 2013; 19(16): 4404-4411. doi: 10.1158/1078-0432.CCR-12-2169
  33. Bandyopadhyay S, Montagna C, Macian F. Silencing of the Il2 gene transcription is regulated by epigenetic changes in anergic T cells. Eur J Immunol 2012; 42(9): 2471-2483. doi: 10.1002/eji.201142307
  34. Akiyama K, Chen C, Wang D et al. Mesenchymal-stemcell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. Cell Stem Cell 2012; 10(5): 544-555. doi: 10.1016/j.stem.2012.03.007
  35. Fife BT, Pauken KE. The role of the PD-1 pathway in autoimmunity and peripheral tolerance. Ann N Y Acad Sci 2011; 1217: 45-59. doi: 10.1111/j.1749-6632.2010.05919.x
  36. Francisco LM, Sage PT, Sharpe AH. The PD-1 pathway in tolerance and autoimmunity Immunol Rev 2010; 236: 219-242. doi: 10.1111/j.1600-065X.2010.00923.x
  37. McCarthy DP, Bryant J, Galvin JP. Tempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cells. Am J Transplant 2015; 15(6): 1475-1483. doi: 10.1111/ajt.13237
  38. Moreau A, Varey E, Bériou G et al. Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials. Front Immunol 2012; 3: 218. doi: 10.3389/ fimmu.2012.00218
  39. Hall BM, Tran GT, Robinson CM et al. Induction of antigen specific CD4(+)CD25(+)Foxp3(+)T regulatory cells from naïve natural thymic derived T regulatory cells. Int Immunopharmacol 2015; 28(2): 875-886. doi: 10.1016/j.intimp.2015.03.049
  40. Vela-Ojeda J, Montiel-Cervantes L, Granados-Lara P et al. Role of CD4+CD25+highFoxp3+CD62L+ regulatory T cells and invariant NKT cells in human allogeneic hematopoietic stem cell transplantation. Stem Cells Dev 2010; 19(3): 333-340. doi: 10.1089/scd.2009.0216
  41. Lal G, Kulkarni N, Nakayama Y et al. Bromberg J.S. IL-10 from marginal zone precursor B cells controls the differentiation of Th17, Tfh and Tfr cells in transplantation tolerance. Immunol Lett 2016; 170: 52-63. doi: 10.1016/j.imlet.2016.01.002
  42. Kawai T, Cosimi AB, Wee SL et al. Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys. Transplantation 2002; 73(11): 1757-1764. doi: 10.1097/00007890-200206150-00011
  43. Nadazdin O, Abrahamian G, Boskovic S et al. Stem cell mobilization and collection for induction of mixed chimerism and renal allograft tolerance in cynomolgus monkeys. J Surg Res 2011; 168(2): 294-300. doi: 10.1016/j.jss.2010.02.027
  44. Peters JH, Hilbrands LB, Koenen HJ et al. Ex vivo generation of human alloantigen-specific regulatory T cells from CD4(pos)CD25(high) T cells for immunotherapy. PLoS One 2008; 3(5): e2233. doi: 10.1371/journal.pone.0002233
  45. Safinia N, Vaikunthanathan T, Fraser H et al. Successful expansion of functional and stable regulatory T cells for immunotherapy in liver transplantation. Oncotarget 2016; 7(7): 75637577. doi: 10.18632/oncotarget.6927
  46. Thorp EB, Stehlik C, Ansari MJ. T-cell exhaustion in allograft rejection and tolerance. Curr Opin Organ Transplant 2015; 20(1): 37-42. doi: 10.1097/MOT.0000000000000153
  47. Valujskikh A, Li XC. Memory T cells and their exhaustive differentiation in allograft tolerance and rejection. Curr Opin Organ Transplant 2012; 17(1): 15-19. doi: 10.1097/ MOT.0b013e32834ee443
  48. Xia CQ, Campbell KA, Clare-Salzler MJ. Extracorporeal photopheresis-induced immune tolerance: a focus on modulation of antigen-presenting cells and induction of regulatory T cells by apoptotic cells. Curr Opin Organ Transplant 2009; 14(4): 338343. doi: 10.1097/MOT.0b013e32832ce943